Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
American Journal of Respiratory and Critical Care Medicine
Journal
Overview
Identity
Overview
Publication Venue For
Association between Inhaled Corticosteroids and Expiratory Central Airway Collapse in Smokers.
. 203:518-521.
2021
Reply to Mezidi et al.
. 203:392-394.
2021
Computed tomography–based airway surface area–to-volume ratio for phenotyping airway remodeling in chronic obstructive pulmonary disease
. 203:185-191.
2021
Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation
. 203:54-66.
2021
Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis
. 200:1402-1413.
2021
Ivacaftor reverses airway mucus abnormalities in a rat model harboring a humanized G551D-CFTR
. 202:1271-1282.
2020
The effect of inhaled corticosteroid withdrawal and baseline inhaled treatment on exacerbations in the IMPACT study a randomized, double-blind, multicenter clinical trial
. 202:1237-1243.
2020
Reply to Suissa
. 202:773-774.
2020
A fatal case of pneumocephalus during computed tomography-guided lung biopsy
. 201:E83-E84.
2020
Reduction in all-cause mortality with fluticasone furoate/umeclidinium/vilanterol in patients with chronic obstructive pulmonary disease
. 201:1508-1516.
2020
Cystic fibrosis: Emergence of highly effective targeted therapeutics and potential clinical implications
. 201:1193-1208.
2020
Reply to de Steenhuijsen Piters and Bogaert
. 201:1311-1312.
2020
Predicting Pneumonia in Chronic Obstructive Pulmonary Disease Have We Unraveled the Network of Risks?
. 201:1026-1027.
2020
Human Fetal Lungs Harbor a Microbiome Signature
. 201:1002-1006.
2020
Disease progression modeling in chronic obstructive pulmonary disease
. 201:294-302.
2020
Clinical development and research applications of the chronic obstructive pulmonary disease assessment test
. 201:1058-1067.
2020
Females with cystic fibrosis demonstrate a differential response profile to ivacaftor compared with males
. 201:996-998.
2020
Hyperoxia injury in the developing lung is mediated by mesenchymal expression of Wnt5A
. 201:1249-1262.
2020
Reply to Gagnon et al.
. 201:120.
2020
Reply to moy
. 200:1443-1444.
2019
Sugarcoating lung injury: A novel role for high-molecular-weight hyaluronan in pneumonia
. 200:1197-1198.
2019
A genetic risk score associated with chronic obstructive pulmonary disease susceptibility and lung structure on computed tomography
. 200:721-731.
2019
Arterial vascular pruning, right ventricular size, and clinical outcomes in chronic obstructive pulmonary disease a longitudinal observational study
. 200:454-461.
2019
Chronic obstructive pulmonary disease in America's black population
. 200:423-430.
2019
Video telehealth pulmonary rehabilitation intervention in chronic obstructive pulmonary disease reduces 30-day readmissions
. 200:511-513.
2019
Update in pulmonary fibrosis 2018
. 200:292-300.
2019
Exposure to greater air pollution when traveling abroad is associated with decreased lung function
. 199:1570-1572.
2019
Update in chronic obstructive pulmonary disease 2018
. 199:1462-1470.
2019
Imaging advances in chronic obstructive pulmonary disease insights from the genetic epidemiology of chronic obstructive pulmonary disease (COPDGene) study
. 199:286-301.
2019
Life-course smoking trajectories and risk for emphysema in middle age: The CARDIA Lung study
. 199:237-240.
2019
Reply to Eapen et al.: Dysfunctional immunity and microbial adhesion molecules in smoking-induced pneumonia
. 199:251-252.
2019
Design of idiopathic pulmonary fibrosis clinical trials in the era of approved therapies
. 200:133-139.
2019
Patient registries in idiopathic pulmonary fibrosis
. 200:160-167.
2019
Reply to Finotti et al.
. 199:1444-1445.
2019
Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis
. 200:199-208.
2019
Transcriptomic signatures in sepsis and a differential response to steroids from the VaNISH randomized trial
. 199:980-986.
2019
ADAM9: A damaging player in chronic obstructive pulmonary disease
. 198:1465-1466.
2018
Nosocomial pneumonia elicits an endothelial proteinopathy: Evidence for a source of neurotoxic amyloids in critically ill patients
. 198:1575-1578.
2018
Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study
. 198:1397-1405.
2018
Macrophage Rac2 is required to reduce the severity of cigarette smoke-induced pneumonia
. 198:1288-1301.
2018
A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE)
. 198:1151-1164.
2018
Ataluren, a new therapeutic for alpha-1 antitrypsin-deficient individuals with nonsense mutations
. 198:1099-1102.
2018
Protein tyrosine phosphatase-N13 promotes myofibroblast resistance to apoptosis in idiopathic pulmonary fibrosis
. 198:914-927.
2018
Maternal smoking induces acquired CFTR dysfunction in neonatal rats
. 198:672-674.
2018
Reversing mechanoinductive DSP expression by CRISPR/dCas9–mediated epigenome editing
. 198:599-609.
2018
Changes in lung clearance index in preschool-aged patients with cystic fibrosis treated with ivacaftor (GOAL): A clinical trial
. 198:526-528.
2018
Defining impaired respiratory health a paradigm shift for pulmonary medicine
. 198:440-446.
2018
Early chronic obstructive pulmonary disease or early detection of mild disease?
. 198:411-412.
2018
Future research directions in pneumonia
. 198:256-263.
2018
Things we “kNOw” and do not “kNOw” about pulmonary hypertension
. 198:151-152.
2018
Exacerbations of chronic obstructive pulmonary disease and cardiac events a post hoc cohort analysis from the SUMMIT randomized clinical trial
. 198:51-57.
2018
Control of breathing in preterm infants: Neonatal ICU and beyond
. 197:1518-1520.
2018
Generic respiratory symptoms and branded lung diseases: Same Difference?
. 197:1521-1523.
2018
HIV gp120 in the lungs of antiretroviral therapy-treated individuals impairs alveolar macrophage responses to pneumococci
. 197:1604-1615.
2018
Respiratory symptoms in young adults and future lung disease the cardia lung study
. 197:1616-1624.
2018
Ivacaftor-treated patients with cystic fibrosis derive long-term benefit despite no short-term clinical improvement
. 197:1483-1486.
2018
Reply to shah et al.
. 197:1363-1364.
2018
Does extracorporeal membrane oxygenation improve survival in pediatric acute respiratory failure?
. 197:1177-1186.
2018
Novel method for noninvasive sampling of the distal airspace in acute respiratory distress syndrome
. 197:1027-1035.
2018
MicroRNA-145 antagonism reverses TGF-b inhibition of F508del CFTR correction in airway Epithelia
. 197:632-643.
2018
Randomized controlled trial of urokinase versus placebo for nondraining malignant pleural effusion
. 197:502-508.
2018
Quantitative evidence for revising the definition of primary graft dysfunction after lung transplant
. 197:235-243.
2018
Cardiac morphometry on computed tomography and exacerbation reduction with β-blocker therapy in chronic obstructive pulmonary disease
. 196:1484-1488.
2017
Signs of gas trapping in normal lung density regions in smokers
. 196:1404-1410.
2017
Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations eICE study results
. 196:1144-1151.
2017
Recovery from critical illness: Physical rehabilitation in the intensive care unit, timing of persistent critical illness, and caregiver outcomes
. 196:1068-1070.
2017
Vascular endothelial mitochondrial function predicts death or pulmonary outcomes in preterm infants
. 196:1040-1049.
2017
Computed tomography measure of lung at risk and lung function decline in chronic obstructive pulmonary disease
. 196:569-576.
2017
Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling
. 196:609-620.
2017
FEV
1
decline in patients with chronic obstructive pulmonary disease: Reply
. 195:1677.
2017
Pulmonary hypertension and precision medicine through the "omics" looking glass
. 195:1558-1560.
2017
Reply: FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease.
. 195:1677.
2017
Association between cardiorespiratory fitness and lung health from young adulthood to middle ages
. 195:1236-1243.
2017
Effect of fluticasone furoate and vilanterol on exacerbations of chronic obstructive pulmonary disease in patients with moderate airflow obstruction
. 195:881-888.
2017
Sequelae of donor-derived mollicutes transmission in lung recipients
. 195:687-689.
2017
Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease
. 195:324-330.
2017
Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study
. 195:67-77.
2017
What is in a pattern? that which we call idiopathic pulmonary fibrosis by any other pattern would behave alike!
. 195:10-12.
2017
All about Asthma: Association with Obstructive Sleep Apnea, Management, and Overlap with Chronic Obstructive Pulmonary Disease
. 194:1423-1425.
2016
National institute of environmental health sciences: 50 years of advancing science and improving lung health
. 194:1190-1195.
2016
Discovery of clinically approved agents that promote suppression of cystic fibrosis transmembrane conductance regulator nonsense mutations
. 194:1092-1103.
2016
Hidden in plain sight: Lung impairment in ischemic heart disease
. 194:528-530.
2016
Reply
. 194:522.
2016
Reply: It Is Too Early to Say No Place for High-Frequency Oscillatory Ventilation in Children with Respiratory Failure.
. 194:522.
2016
Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease
. 194:178-184.
2016
Compartmentalization is key in limiting nitric oxide scavenging by cell-free hemoglobin
. 193:1072-1074.
2016
Reply
. 193:1068-1069.
2016
Reply: Do We Really Know How to Use High-Frequency Oscillatory Ventilation in Critically Ill Children?
. 193:1068-1069.
2016
Oxidative modifications of protein tyrosyl residues are increased in plasma of human subjects with interstitial lung disease
. 193:861-866.
2016
Early high-frequency oscillatory ventilation in pediatric acute respiratory failure: A propensity score analysis
. 193:495-503.
2016
Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis
. 192:1462-1474.
2015
Recovery of acquired cystic fibrosis transmembrane conductance regulator dysfunction after smoking cessation
. 192:1521-1524.
2015
Endothelin-1 pathway polymorphisms and outcomes in pulmonary arterial hypertension
. 192:1345-1354.
2015
A fragment in time: Elastin peptides and progression of emphysema
. 192:1141-1143.
2015
Loss of Lung Health from Young Adulthood and Cardiac Phenotypes in Middle Age.
. 192:76-85.
2015
Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation
. 191:455-463.
2015
A randomized, placebo-controlled trial of roflumilast effect on proline-glycine-proline and neutrophilic inflammation in chronic obstructive pulmonary disease
. 192:934-942.
2015
Blue Journal Conference: Aging and susceptibility to lung disease
. 191:261-269.
2015
Cardiotoxicity during invasive pneumococcal disease
. 191:739-745.
2015
Noninvasive computed tomography-based risk stratification of lung adenocarcinomas in the national lung screening trial
. 192:737-744.
2015
Extracorporeal membrane oxygenation for acute respiratory failure in adults: The need for pulmonary INTERMACS
. 190:1321-1322.
2014
Is pulmonary hypertension a metabolic disease?
. 190:973-975.
2014
An aberrant leukotriene A
4
hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease
. 190:51-61.
2014
Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation
. 189:1564-1567.
2014
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy
. 189:1503-1508.
2014
C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis
. 189:966-974.
2014
Reply
. 189:869-870.
2014
Tertiary lymphoid structures target the antitumor immune response to lung cancer
. 189:767-769.
2014
Genetic variation in the prostaglandin E
2
pathway is associated with primary graft dysfunction
. 189:567-575.
2014
A functional anatomic defect of the cystic fibrosis airway
. 190:421-432.
2014
A novel tumor necrosis factor-mediated mechanism of direct epithelial sodium channel activation
. 190:522-532.
2014
Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis
. 190:175-184.
2014
Genome-wide association identifies regulatory loci associated with distinct local histogram emphysema patterns
. 190:399-409.
2014
Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes
. 190:445-455.
2014
Thromboendarterectomy for chronic thromboembolic pulmonary hypertension in hereditary hemorrhagic telangiectasia
. 189:112-114.
2014
Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide
. 188:1407-1412.
2013
Sleep apnea is associated with subclinical myocardial injury in the community: The ARIC-SHHS study
. 188:1460-1465.
2013
Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function
. 188:1321-1330.
2013
Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.
. 188:1321-1330.
2013
AECOPD: Acute exacerbations of chronic obstructive cardiopulmonary disease?
. 188:1046-1048.
2013
S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis
. 188:1137-1146.
2013
High-frequency oscillatory ventilation, microRNAs in pulmonary hypertension, and gastric residual volumes.
. 188:508-509.
2013
Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications
. 188:231-239.
2013
Cyclooxygenase-2 inhibits T helper cell type 9 differentiation during allergic lung inflammation via down-regulation of IL-17RB
. 187:812-822.
2013
Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses
. 187:768-775.
2013
Clinical risk factors for primary graft dysfunction after lung transplantation
. 187:527-534.
2013
A young hispanic with c.1646G>A mutation exhibits severe cystic fibrosis lung disease: Is ivacaftor an option for therapy?
. 186:694-696.
2012
Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction
. 186:622-632.
2012
Altered DNA methylation profile in idiopathic pulmonary fibrosis
. 186:525-535.
2012
Variation in PTX3 is associated with primary graft dysfunction after lung transplantation
. 186:546-552.
2012
Retinoic acid-related orphan receptor-α is induced in the setting of DNA damage and promotes pulmonary emphysema
. 186:412-419.
2012
Modern age pathology of pulmonary arterial hypertension
. 186:261-272.
2012
A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis
. 186:88-95.
2012
Update in diffuse parenchymal lung disease 2011
. 186:24-29.
2012
Computed axial tomography scans, calories, and computers
. 185:584-585.
2012
Lung endothelial Ca
2+
and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6
. 185:160-170.
2012
Obesity and primary graft dysfunction after lung transplantation: The lung transplant outcomes group obesity study
. 184:1055-1061.
2011
A Trojan horse strategy to deliver amikacin to mycobacterial granulomas [1]
. 184:860.
2011
The missing link between smoking and COPD autoreactivity?
. 184:747-749.
2011
Cyclooxygenase-2 regulates Th17 cell differentiation during allergic lung inflammation
. 184:37-49.
2011
Active and passive cigarette smoking and acute lung injury after severe blunt trauma
. 183:1660-1665.
2011
Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants
. 183:1715-1722.
2011
ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio
. 183:1344-1353.
2011
Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort
. 183:885-890.
2011
Recommended Reading from the University of Alabama Fellows: J. Allen Cooper, Program Director.
. 183:411-412.
2011
Targeted delivery of amikacin into granuloma
. 182:1546-1553.
2010
Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils
. 182:1516-1523.
2010
Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair
. 182:1030-1037.
2010
Cystic fibrosis pulmonary guidelines: Pulmonary complications: Hemoptysis and pneumothorax
. 182:298-306.
2010
Is there a doctor in the house? The downside of 24/7 attending coverage in academic intensive care units
. 181:1280-1281.
2010
Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results
. 181:604-610.
2010
Latent herpesvirus infection augments experimental pulmonary fibrosis
. 181:465-477.
2010
Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease
. 181:438-445.
2010
What is autoimmunity and why is it likely to be important in chronic lung disease?
. 181:4-5.
2010
Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction
. 180:1010-1015.
2009
Deletion of Pten expands lung epithelial progenitor pools and confers resistance to airway injury
. 180:701-712.
2009
Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease
. 180:499-505.
2009
Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension
. 180:468-474.
2009
Are telomere lengths of leukocytes from patients with pulmonary fibrosis really genetically determined?
. 179:852.
2009
Bcl-2 suppresses sarcoplasmic/endoplasmic reticulum Ca21-ATPase expression in cystic fibrosis airways role in oxidant-mediated cell death
. 179:816-826.
2009
Biologic lung volume reduction in advanced upper lobe emphysema phase 2 results
. 179:791-798.
2009
Antiinflammatory effects of hydrogen peroxide in neutrophil activation and acute lung injury
. 179:694-704.
2009
Gamma Delta T Cells Attenuate Pulmonary Fibrosis through the Production of IP-10
. 179.
2009
Regulation of Thy-1 Expression by Histone Modifications in Lung Fibroblast.
. 179.
2009
STAT4-Dependent, T-Bet Independent Lung Immune Responses to Pneumocystis
. 179.
2009
The Absence of Hck, Fgr and Lyn Tyrosine Kinases Augments Lung Innate Immune Responses to Pneumocystis
. 179.
2009
Potential role of high-mobility group box 1 in cystic fibrosis airway disease
. 178:822-831.
2008
CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients
. 178:765-773.
2008
Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury
. 178:168-179.
2008
Screening contacts of tuberculosis: Overcoming obstacles with an old tool
. 177:939-940.
2008
Autoantibodies in patients with chronic obstructive pulmonary disease
. 177:156-163.
2008
BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
. 177:75-81.
2008
On treatment outcomes of patients with HIV and tuberculosis [1]
. 177:121.
2008
Ozone, a malady for all ages
. 176:107-108.
2007
Importance of phosphoinositide 3-kinase γ in the host defense against pneumococcal infection
. 175:958-966.
2007
One more prediction rule: Has anything new been added? [1]
. 175:743.
2007
Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction
. 175:69-74.
2007
Children's secondhand smoke exposure in African-American families
2007
Measurement of secondhand smoke exposure in children using a point of care urine dipstick assay for cotinine
2007
Modulatory role for retinoid-related orphan receptor α in allergen-induced lung inflammation
. 174:1299-1309.
2006
Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: An NHLBI workshop report
. 174:373-378.
2006
Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus
. 173:673-682.
2006
Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection
. 173:334-344.
2006
Bombesin-like peptides: Modulators of inflammation in acute lung injury?
. 173:1-2.
2006
Reevaluating neonatal resuscitation with 100% oxygen
. 172:1360-1361.
2005
The mysterious pulmonary brush cell: A cell in search of a function
. 172:136-139.
2005
Oleic acid damages ion transport promotes alveolar edema: The dark side of healthy living
. 171:424-425.
2005
Loss of bone density with inhaled triamcinoline in lung health study II
. 170:1302-1309.
2004
Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys
. 170:1153-1157.
2004
Asthma self-management, self-efficacy, and resilience in adolescents attending asthma camp
2004
Parent and child agreement on questionnaires for asthma case detection
2004
A Genome-Wide Scan of Pulmonary Function Measures in the National Heart, Lung, and Blood Institute Family Heart Study
. 167:1528-1533.
2003
Statin use is associated with improved function and survival of lung allografts
. 167:1271-1278.
2003
Nontuberculous mycobacteria: I: Multicenter prevalence study in cystic fibrosis
. 167:828-834.
2003
Secondhand smoke exposure and school-age children
2003
A decision tree for tuberculosis contact investigation
. 166:1122-1127.
2002
Fibrinolysis in the pleural space. Breaking the bonds that bind
. 166:909-910.
2002
ATS statement: Guidelines for the six-minute walk test
. 166:111-117.
2002
Oligoclonal CD4
+
T cell expansions in lung transplant recipients with obliterative bronchiolitis
. 165:1439-1444.
2002
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial
. 165:800-804.
2002
Genetic loci influencing lung function: A genomewide scan in the Framingham Study
. 165:795-799.
2002
Asthma education in elementary school children and teachers
2002
ETS avoidance behaviors
2002
Heritability of longitudinal change in lung function: The Framingham study
. 164:1655-1659.
2001
Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis
. 164:193-196.
2001
Attenuation of interleukin 8-induced nasal inflammation by an inhibitor peptide
. 163:1198-1205.
2001
Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis
. 163:1683-1692.
2001
Increased levels of nitrate and surfactant protein A nitration in the pulmonary edema fluid of patients with acute lung injury
. 163:166-172.
2001
Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome
. 163:503-510.
2001
Trends in asthma prevalence and morbidity in Head Start graduates
2001
Use of a long-acting inhaled β
2
-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease
. 163:1087-1092.
2001
Talc induces apoptosis in human malignant mesothelioma cells in vitro.
. 161:595-600.
2000
Asthma prevalence and morbidity in Head Start Graduates
2000
Cyclophosphamide prevents systemic keratinocyte growth factor-induced up-regulation of surfactant protein A after allogeneic transplant in mice
. 162:1884-1890.
2000
DETANONOate, a nitric oxide donor, decreases amiloride-sensitive alveolar fluid clearance in rabbits
. 161:1154-1160.
2000
Heterogeneous geographic distribution of inner city pediatric asthma admissions in Birmingham
2000
Management of malignant pleural effusions
. 162:1987-2001.
2000
Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts
. 161:2035-2042.
2000
Results of a school-based multi-stage screening procedure for asthma
2000
School environments and children with asthma
2000
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: The lung health study
. 161:381-390.
2000
Talc induces apoptosis in human malignant mesothelioma cells in vitro
. 161:595-600.
2000
Helper T cell type 1 and 2 cytokines regulate C-C chemokine expression in mouse pleural mesothelial cells.
. 159:1653-1659.
1999
Acid-induced lung injury: Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits
. 160:1450-1456.
1999
Helper T cell type 1 and 2 cytokines regulate C-C chemokine expression in mouse pleural mesothelial cells
. 159:1653-1659.
1999
Identification of questions that best predict new diagnosis of asthma in children
1999
Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits
. 160:1443-1449.
1999
Leptin prevents respiratory depression in obesity
. 159:1477-1484.
1999
Reporting of symptoms in childhood asthma: Parent and child comparisons
1999
Advances in prevention and education in lung disease
. 157.
1998
Segregation analysis of pulmonary function among families in the framingham study
. 157:1445-1451.
1998
Talc-induced expression of C-C and C-X-C chemokines and intercellular adhesion molecule-1 in mesothelial cells
. 158:971-978.
1998
Upregulation of xanthine oxidase by lipopolysaccharide, interleukin-1, and hypoxia: Role in acute lung injury
. 158:299-305.
1998
Biological markers of acute lung injury: Prognostic and pathogenetic significance
. 155:1187-1205.
1997
The epithelium as a target of glucocorticoid action in the treatment of asthma.
. 154:S16-S19.
1996
Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate ± amiloride in normal human adults
. 154:217-223.
1996
Aerosolized cyclosporine in lung recipients with refractory chronic rejection
. 153:1451-1455.
1996
Lung injury after hepatoenteric ischemia-reperfusion: Role of xanthine oxidase
. 154:1364-1369.
1996
The epithelium as a target of glucocorticoid action in the treatment of asthma
. 154.
1996
Transmission of Mycobacterium tuberculosis to recipients of single lung transplants from the same donor
. 153:1166-1168.
1996
Clinical risk factors for pulmonary barotrauma: A multivariate analysis
. 152:1235-1240.
1995
Delivery and distribution of aerosolized cyclosporine in lung allograft recipients
. 151:516-521.
1995
Hyperoxic lung injury reduces exogenous surfactant clearance in vivo
. 151:1843-1847.
1995
Laboratory contamination of Mycobacterium tuberculosis cultures
. 152:1702-1704.
1995
Resistance of the alveolar epithelium to injury from septic shock in sheep
. 151:1093-1100.
1995
Development of pulmonary infection in mice inoculated with Blastomyces dermatitidis conidia.
. 149:500-509.
1994
Measures for use in asthma clinical research. Overview of the NIH workshop.
. 149:S1-S8.
1994
A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation
. 150:146-152.
1994
Development of pulmonary infection in mice inoculated with Blastomyces dermatitidis conidia
. 149:500-509.
1994
Load detection in subjects with sleep-induced upper airway obstruction
. 149:727-730.
1994
Identity
International Standard Serial Number (issn)
1073-449X
Electronic International Standard Serial Number (eissn)
1073-449X
1535-4970